Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Boosting of Olaparib (PROACTIVE)
NCT05078671Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cobicistat in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), breast cancer, prostate cancer (PCa), sponsored by Radboud University Medical Center. Started Dec 2021; status: recruiting.
02
Drugs
cobicistat
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)breast cancerprostate cancer (PCa)
Beyond the preview
Go deeper on NCT05078671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05078671.